Medifast Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Medifast Inc 's ROA in the second quarter of 2026?
Medifast Inc recorded a cumulative net loss of $-26 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -9.1%.

However, within the Consumer Non Cyclical sector 117 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3107, from total ROA ranking in the first quarter of 2026 at 3585.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	32.82 %	-9.99 %	-5.69 %	-2.82 %	-2.85 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-26	-20	-19	0	4
Return On Assets (TTM)	-9.1 %	-7.72 %	-7.01 %	0.09 %	1.34 %
MED's Total Ranking	# 3107	# 3585	# 2543	# 2039	# 2884
Total Assets (TTM) in million	358	252	248	268	269
Seq. Total Assets Change	41.92 %	1.64 %	-7.54 %	-0.42 %	-3.81 %
Seq. Net Income Change	-	-	-	-	-

MED's 5 Years Annual ROA >> Back to MED Management Effectiveness >> Compare MED ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 38
Sector	# 118
Overall	# 3161

Return On Assets Statistics
High	Average	Low
49.03 %	22.9 %	-9.96 %
(Jun 30 2021)		(Jun 30 2026)

Financial Statements
Medifast Inc 's Assets	$ 358 million	MED's Balance sheet
Medifast Inc 's Income	$ -3 million	Quarterly MED's Income Statement
MED's Income by Division		See MED's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-5.69 %	-9.49 %	-1.18 %	-20.76 %	38.98 %
Total Assets in million	248	263	290	294	371
Y / Y Net Income Change	-	-97.9 %	-30.75 %	-12.48 %	59.47 %
Net Income in million	-19	2	99	144	164
Annual Return On Assets	-7.53 %	0.8 %	34.22 %	48.84 %	44.21 %

MED's 5 Years Annual ROA >> Back to MED Management Effectiveness >> Compare MED ROA to its Competitors

More Return On Assets Ratios
MED's' Return on Assets at Yahoo Finance
Food Processing Industry Return On Assets Trends and Statistics
Consumer Non Cyclical Sector Roa Statistics
Roa Trends for overall market
MED's Roa Ratio versus Food Processing Industry, Consumer Non Cyclical Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MED's Competitors
Subscribers only: Roa for Medifast Inc 's Suppliers
Subscribers only: Return On Assets for MED's Customers

You may also want to know
MED's Roi	MED's Inventory Turnover Ratio	MED's Growth Rates	MED's Dividend Comparisons
	MED's Profitability Ratios	MED's Asset Turnover Ratio	MED's Dividend Growth
MED's Roe	MED's Valuation Ratios	MED's Financial Strength Ratios	MED's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Consumer Non Cyclical Sector

ROA

Date modified: 2026-09-13T23:28:36+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.